Calypso Biotech

Calypso Biotech

Biopharmaceutical company, spin-off from Merck Serono, focused on developing antibody therapies up to clinical proof-of-concept for the treatment of diseases with large unmet medical needs
Amsterdam Netherlands (HQ), Plan-les-Ouates Switzerland

Calypso Biotech Company information

Edit
Date
Employees
8 people
Ownership
Firm valuation
€80—120m (Dealroom.co estimates Feb 2019.)
  • Edit
DateInvestorsAmountRound
$3.3mSEED
€2.5mSEED
€20mSERIES A
Total Funding€25.5m

Recent News about Calypso Biotech

Edit
Lists
LocationEdit
Gustav Mahlerplein 102, 1082 MA Amsterdam, Netherlands
Are you an employee or an investor of this company?
Add your profile